Skip to content

Accrued interest at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$4.85M

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-14.5%
Enterprise value$1.21B+2.6%
P/E183.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPayableCurrent.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s accrued interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s accrued interest?
Pacira BioSciences, Inc. (PCRX) reported accrued interest of $2.31M in Q1 2026.
How has Pacira BioSciences, Inc.'s accrued interest changed year-over-year?
Pacira BioSciences, Inc.'s accrued interest increased by 477.0% year-over-year, from $400K to $2.31M.
What is the long-term trend for Pacira BioSciences, Inc.'s accrued interest?
Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s accrued interest has grown at a -13.3% compound annual growth rate (CAGR), from $1.6M to $782K.
What does accrued interest mean?
Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.